Trial · NCT02129075
Adverse events52
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 52
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | General disorders and administration site conditions | General disorders | Arm I (CDX-301, CDX-1401, and Poly-ICLC) | 30 | 30 | 509 |
| other | General disorders and administration site conditions | General disorders | Arm II (CDX-1401 and Poly-ICLC) | 30 | 30 | 322 |
| other | Nervous system disorders | Nervous system disorders | Arm I (CDX-301, CDX-1401, and Poly-ICLC) | 17 | 30 | 35 |
| other | Nervous system disorders | Nervous system disorders | Arm II (CDX-1401 and Poly-ICLC) | 19 | 30 | 49 |
| other | Musculoskeletal and connective tissue disorders | Musculoskeletal and connective tissue disorders | Arm I (CDX-301, CDX-1401, and Poly-ICLC) | 20 | 30 | 56 |
| other | Musculoskeletal and connective tissue disorders | Musculoskeletal and connective tissue disorders | Arm II (CDX-1401 and Poly-ICLC) | 18 | 30 | 33 |
| other | Gastrointestinal disorders | Gastrointestinal disorders | Arm I (CDX-301, CDX-1401, and Poly-ICLC) | 15 | 30 | 37 |
| other | Gastrointestinal disorders | Gastrointestinal disorders | Arm II (CDX-1401 and Poly-ICLC) | 17 | 30 | 44 |
| other | Investigations | Investigations | Arm I (CDX-301, CDX-1401, and Poly-ICLC) | 14 | 30 | 43 |
| other | Investigations | Investigations | Arm II (CDX-1401 and Poly-ICLC) | 14 | 30 | 49 |
| other | Skin and subcutaneous tissue disorders | Skin and subcutaneous tissue disorders | Arm I (CDX-301, CDX-1401, and Poly-ICLC) | 15 | 30 | 21 |
| other | Skin and subcutaneous tissue disorders | Skin and subcutaneous tissue disorders | Arm II (CDX-1401 and Poly-ICLC) | 14 | 30 | 24 |
| other | Metabolism and nutrition disorders | Metabolism and nutrition disorders | Arm I (CDX-301, CDX-1401, and Poly-ICLC) | 15 | 30 | 51 |
| other | Metabolism and nutrition disorders | Metabolism and nutrition disorders | Arm II (CDX-1401 and Poly-ICLC) | 12 | 30 | 28 |
| other | Respiratory, thoracic and mediastinal disorders | Respiratory, thoracic and mediastinal disorders | Arm I (CDX-301, CDX-1401, and Poly-ICLC) | 13 | 30 | 27 |
| other | Respiratory, thoracic and mediastinal disorders | Respiratory, thoracic and mediastinal disorders | Arm II (CDX-1401 and Poly-ICLC) | 13 | 30 | 24 |
| other | Blood and lymphatic system disorders | Blood and lymphatic system disorders | Arm I (CDX-301, CDX-1401, and Poly-ICLC) | 13 | 30 | 30 |
| other | Blood and lymphatic system disorders | Blood and lymphatic system disorders | Arm II (CDX-1401 and Poly-ICLC) | 10 | 30 | 17 |
| other | Infections and infestations | Infections and infestations | Arm I (CDX-301, CDX-1401, and Poly-ICLC) | 7 | 30 | 10 |
| other | Infections and infestations | Infections and infestations | Arm II (CDX-1401 and Poly-ICLC) | 9 | 30 | 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02129075/events